Contract Manufacturing

valneva-is-selling-its-clinical-manufacturing-operations-cmo-in-nantes-france-to-biological-e

India's Biological E to buy French Valneva's CMO unit

  • India
  • |
  • News

Singapore: France-based biotech firm Valneva is selling its clinical manufacturing operations (CMO) in Nantes to India-based Biological E. The sale of this unit, which is dedicated to the manufacturing of clinical trial materials, is part... Read more

good-news-for-alzheimer-s-disease-patients-shasun-and-debiopharm-will-manufacture-brain-drug-huperzine-a

Shasun, Debiopharm to manufacture brain drug


  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Shasun Pharmaceuticals and Debiopharm Group entered into a licensing agreement for the manufacturing and commercialization... Read more

china-cro-inspection

China CRO facility undergoes US FDA inspection


  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: For the first time, the US FDA has completed an inspection in China under its combined clinical trial and bioresearch... Read more

ajinomoto-acquires-althea

Ajinomoto acquires US firm Althea

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Japan-headquartered Ajinomoto has entered into a definitive agreement to acquire Althea Technologies, a US-based provider of... Read more

gvk-biosciences-selects-genesis-genetics-asia-gga-its-informatics-distributor-in-taiwan

Genesis Genetics is GVK Bio distributor in Taiwan

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Hyderabad: GVK Biosciences has selected Genesis Genetics Asia (GGA) as its distributor for its informatics database products and services... Read more

commercialization-agreement

Samsung Bioepis, Merck in biosimilars deal

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Seoul-based Samsung Bioepis and MSD, known as Merck in the US and Canada, have entered into an agreement to develop and commercialize... Read more

collaboration-viropro-oncobiologics

Viropro, Oncobiologics sign commercialization deal

  • Malaysia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Viropro has signed a biosimilars collaboration agreement with New Jersey-based Oncobiologics for the rights to manufacture six... Read more

kemwell-biopharma-india-appoints-dr-ninad-deshpanday-as-president-of-r-d

Ninad Deshpanday is Kemwell R&D president

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Bangalore: India-based Kemwell Biopharma appointed Dr Ninad Deshpanday as president of R&D. Dr Deshpanday has over 22 years of experience... Read more

italian-health-robotics-and-japanese-robotics-firm-tosho-join-hands-for-healthcare-sector-deal

Italian, Japanese robot firms sign healthcare deal

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Italy-headquartered Health Robotics has signed two long-term contract extensions of its exclusive partnership with Tosho, a Japanese... Read more

preclinical-facility-of-vivo-bio-tech-at-hyderabad

Vivo Bio Tech to breed Taconic mouse models in India

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Bangalore: Taconic, a leading provider of life sciences solutions, and Vivo Bio Tech, a full-service contract research organization, have... Read more

Biotech-310x175_copy

US FDA finds cGMP violation at Taiwan facility

  • Taiwan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The US Food and Drug Administration (FDA) has issued a warning letter to Taiwan Three Mast Pharmaceutical after an inspection... Read more

marck-approval-south-africa

Marck products get approval in South Africa

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Mumbai: Marck Biosciences, an Indian manufacturer and marketer of sterile dosages and Blow-Fill-Seal (BFS) specialist, was granted approval... Read more

Previous 1 3 4

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X